nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM3—epilepsy syndrome	0.138	0.329	CbGaD
Oxybutynin—CHRM1—epilepsy syndrome	0.128	0.306	CbGaD
Oxybutynin—CHRM2—epilepsy syndrome	0.105	0.25	CbGaD
Oxybutynin—CYP2D6—epilepsy syndrome	0.048	0.115	CbGaD
Oxybutynin—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0243	0.0712	CbGbCtD
Oxybutynin—CYP2C8—Trimethadione—epilepsy syndrome	0.0218	0.0636	CbGbCtD
Oxybutynin—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0205	0.0598	CbGbCtD
Oxybutynin—CYP3A5—Carbamazepine—epilepsy syndrome	0.0153	0.0447	CbGbCtD
Oxybutynin—CYP2C8—Carbamazepine—epilepsy syndrome	0.0147	0.043	CbGbCtD
Oxybutynin—CYP2C8—Primidone—epilepsy syndrome	0.0137	0.0401	CbGbCtD
Oxybutynin—CYP3A5—Phenytoin—epilepsy syndrome	0.0137	0.0401	CbGbCtD
Oxybutynin—CYP2C8—Phenytoin—epilepsy syndrome	0.0132	0.0385	CbGbCtD
Oxybutynin—CYP2C8—Propofol—epilepsy syndrome	0.0123	0.0359	CbGbCtD
Oxybutynin—CYP3A5—Phenobarbital—epilepsy syndrome	0.0122	0.0357	CbGbCtD
Oxybutynin—CYP3A5—Midazolam—epilepsy syndrome	0.0121	0.0352	CbGbCtD
Oxybutynin—CYP2C8—Phenobarbital—epilepsy syndrome	0.0118	0.0343	CbGbCtD
Oxybutynin—CYP3A5—Diazepam—epilepsy syndrome	0.0116	0.0339	CbGbCtD
Oxybutynin—CYP2C8—Diazepam—epilepsy syndrome	0.0111	0.0326	CbGbCtD
Oxybutynin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00949	0.0277	CbGbCtD
Oxybutynin—CYP3A5—Valproic Acid—epilepsy syndrome	0.00913	0.0267	CbGbCtD
Oxybutynin—CYP3A4—Felbamate—epilepsy syndrome	0.00883	0.0258	CbGbCtD
Oxybutynin—CYP3A4—Trimethadione—epilepsy syndrome	0.00883	0.0258	CbGbCtD
Oxybutynin—CYP2C8—Valproic Acid—epilepsy syndrome	0.00878	0.0257	CbGbCtD
Oxybutynin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0083	0.0243	CbGbCtD
Oxybutynin—CYP2D6—Propofol—epilepsy syndrome	0.00784	0.0229	CbGbCtD
Oxybutynin—CYP3A4—Clonazepam—epilepsy syndrome	0.0075	0.0219	CbGbCtD
Oxybutynin—CYP3A4—Clobazam—epilepsy syndrome	0.00719	0.021	CbGbCtD
Oxybutynin—CYP3A4—Rufinamide—epilepsy syndrome	0.00612	0.0179	CbGbCtD
Oxybutynin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00596	0.0174	CbGbCtD
Oxybutynin—CYP3A4—Primidone—epilepsy syndrome	0.00557	0.0163	CbGbCtD
Oxybutynin—CYP3A4—Phenytoin—epilepsy syndrome	0.00535	0.0156	CbGbCtD
Oxybutynin—CYP3A4—Propofol—epilepsy syndrome	0.00499	0.0146	CbGbCtD
Oxybutynin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00477	0.0139	CbGbCtD
Oxybutynin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00477	0.0139	CbGbCtD
Oxybutynin—CYP3A4—Midazolam—epilepsy syndrome	0.0047	0.0137	CbGbCtD
Oxybutynin—CYP3A4—Diazepam—epilepsy syndrome	0.00452	0.0132	CbGbCtD
Oxybutynin—CYP3A4—Zonisamide—epilepsy syndrome	0.00441	0.0129	CbGbCtD
Oxybutynin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00356	0.0104	CbGbCtD
Oxybutynin—CYP3A4—Topiramate—epilepsy syndrome	0.00321	0.00939	CbGbCtD
Oxybutynin—Hexylcaine—SCN3A—epilepsy syndrome	0.000457	0.1	CrCbGaD
Oxybutynin—Cycrimine—CHRM1—epilepsy syndrome	0.000381	0.0836	CrCbGaD
Oxybutynin—Oxyphenonium—CHRM3—epilepsy syndrome	0.000324	0.0712	CrCbGaD
Oxybutynin—Hexylcaine—SCN1A—epilepsy syndrome	0.000321	0.0705	CrCbGaD
Oxybutynin—Oxyphenonium—CHRM1—epilepsy syndrome	0.000302	0.0664	CrCbGaD
Oxybutynin—Hexylcaine—SCN2A—epilepsy syndrome	0.000283	0.0621	CrCbGaD
Oxybutynin—Oxyphencyclimine—CHRM3—epilepsy syndrome	0.000276	0.0606	CrCbGaD
Oxybutynin—Oxyphencyclimine—CHRM1—epilepsy syndrome	0.000257	0.0565	CrCbGaD
Oxybutynin—Procyclidine—CHRM3—epilepsy syndrome	0.000234	0.0515	CrCbGaD
Oxybutynin—Procyclidine—CHRM1—epilepsy syndrome	0.000219	0.048	CrCbGaD
Oxybutynin—Trihexyphenidyl—CHRM3—epilepsy syndrome	0.000214	0.0471	CrCbGaD
Oxybutynin—Oxyphencyclimine—CHRM2—epilepsy syndrome	0.00021	0.0461	CrCbGaD
Oxybutynin—Trihexyphenidyl—CHRM1—epilepsy syndrome	0.0002	0.0439	CrCbGaD
Oxybutynin—Glycopyrrolate—CHRM3—epilepsy syndrome	0.000198	0.0435	CrCbGaD
Oxybutynin—Glycopyrrolate—CHRM1—epilepsy syndrome	0.000184	0.0405	CrCbGaD
Oxybutynin—Procyclidine—CHRM2—epilepsy syndrome	0.000178	0.0392	CrCbGaD
Oxybutynin—Trihexyphenidyl—CHRM2—epilepsy syndrome	0.000163	0.0359	CrCbGaD
Oxybutynin—Glycopyrrolate—CHRM2—epilepsy syndrome	0.000151	0.0331	CrCbGaD
Oxybutynin—CHRM2—forebrain—epilepsy syndrome	8.1e-05	0.0562	CbGeAlD
Oxybutynin—CHRM2—telencephalon—epilepsy syndrome	7.45e-05	0.0517	CbGeAlD
Oxybutynin—CHRM1—forebrain—epilepsy syndrome	7.38e-05	0.0512	CbGeAlD
Oxybutynin—CHRM1—telencephalon—epilepsy syndrome	6.78e-05	0.0471	CbGeAlD
Oxybutynin—CHRM5—head—epilepsy syndrome	6.76e-05	0.0469	CbGeAlD
Oxybutynin—CHRM3—forebrain—epilepsy syndrome	6.6e-05	0.0458	CbGeAlD
Oxybutynin—CYP2D6—hindbrain—epilepsy syndrome	6.45e-05	0.0448	CbGeAlD
Oxybutynin—CHRM5—nervous system—epilepsy syndrome	6.41e-05	0.0445	CbGeAlD
Oxybutynin—CHRM5—central nervous system—epilepsy syndrome	6.17e-05	0.0428	CbGeAlD
Oxybutynin—CHRM3—telencephalon—epilepsy syndrome	6.07e-05	0.0421	CbGeAlD
Oxybutynin—CHRM5—brain—epilepsy syndrome	4.9e-05	0.034	CbGeAlD
Oxybutynin—CHRM2—head—epilepsy syndrome	4.64e-05	0.0322	CbGeAlD
Oxybutynin—CHRM2—nervous system—epilepsy syndrome	4.4e-05	0.0305	CbGeAlD
Oxybutynin—CHRM2—central nervous system—epilepsy syndrome	4.24e-05	0.0294	CbGeAlD
Oxybutynin—CHRM1—head—epilepsy syndrome	4.22e-05	0.0293	CbGeAlD
Oxybutynin—CHRM1—nervous system—epilepsy syndrome	4e-05	0.0278	CbGeAlD
Oxybutynin—CHRM1—central nervous system—epilepsy syndrome	3.85e-05	0.0267	CbGeAlD
Oxybutynin—CHRM3—head—epilepsy syndrome	3.78e-05	0.0262	CbGeAlD
Oxybutynin—CYP2D6—brainstem—epilepsy syndrome	3.7e-05	0.0257	CbGeAlD
Oxybutynin—CHRM3—nervous system—epilepsy syndrome	3.58e-05	0.0249	CbGeAlD
Oxybutynin—CYP2D6—forebrain—epilepsy syndrome	3.57e-05	0.0248	CbGeAlD
Oxybutynin—CHRM3—central nervous system—epilepsy syndrome	3.45e-05	0.0239	CbGeAlD
Oxybutynin—CHRM2—brain—epilepsy syndrome	3.36e-05	0.0233	CbGeAlD
Oxybutynin—CYP2D6—telencephalon—epilepsy syndrome	3.28e-05	0.0228	CbGeAlD
Oxybutynin—Pruritus—Phenytoin—epilepsy syndrome	3.26e-05	0.000191	CcSEcCtD
Oxybutynin—Connective tissue disorder—Topiramate—epilepsy syndrome	3.26e-05	0.000191	CcSEcCtD
Oxybutynin—Nausea—Levetiracetam—epilepsy syndrome	3.26e-05	0.000191	CcSEcCtD
Oxybutynin—Rash—Vigabatrin—epilepsy syndrome	3.25e-05	0.000191	CcSEcCtD
Oxybutynin—Dizziness—Felbamate—epilepsy syndrome	3.25e-05	0.000191	CcSEcCtD
Oxybutynin—Dermatitis—Vigabatrin—epilepsy syndrome	3.25e-05	0.000191	CcSEcCtD
Oxybutynin—Urethral disorder—Topiramate—epilepsy syndrome	3.25e-05	0.000191	CcSEcCtD
Oxybutynin—Pruritus—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.00019	CcSEcCtD
Oxybutynin—Convulsion—Pregabalin—epilepsy syndrome	3.24e-05	0.00019	CcSEcCtD
Oxybutynin—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.24e-05	0.00019	CcSEcCtD
Oxybutynin—Vision blurred—Gabapentin—epilepsy syndrome	3.23e-05	0.00019	CcSEcCtD
Oxybutynin—Headache—Vigabatrin—epilepsy syndrome	3.23e-05	0.00019	CcSEcCtD
Oxybutynin—Hypertension—Pregabalin—epilepsy syndrome	3.23e-05	0.000189	CcSEcCtD
Oxybutynin—Vomiting—Diazepam—epilepsy syndrome	3.23e-05	0.000189	CcSEcCtD
Oxybutynin—Anorexia—Valproic Acid—epilepsy syndrome	3.22e-05	0.000189	CcSEcCtD
Oxybutynin—Rash—Diazepam—epilepsy syndrome	3.2e-05	0.000188	CcSEcCtD
Oxybutynin—Dermatitis—Diazepam—epilepsy syndrome	3.2e-05	0.000188	CcSEcCtD
Oxybutynin—Visual impairment—Topiramate—epilepsy syndrome	3.19e-05	0.000187	CcSEcCtD
Oxybutynin—Arthralgia—Pregabalin—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Oxybutynin—Chest pain—Pregabalin—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Oxybutynin—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Oxybutynin—Dizziness—Zonisamide—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Oxybutynin—Headache—Diazepam—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Oxybutynin—Anxiety—Pregabalin—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Oxybutynin—Diarrhoea—Clonazepam—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.16e-05	0.000186	CcSEcCtD
Oxybutynin—Hypotension—Valproic Acid—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Oxybutynin—Asthenia—Carbamazepine—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Oxybutynin—Agitation—Gabapentin—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Oxybutynin—Diarrhoea—Phenytoin—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Oxybutynin—Discomfort—Pregabalin—epilepsy syndrome	3.14e-05	0.000185	CcSEcCtD
Oxybutynin—Nausea—Fosphenytoin—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Oxybutynin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.13e-05	0.000184	CcSEcCtD
Oxybutynin—Angioedema—Gabapentin—epilepsy syndrome	3.13e-05	0.000184	CcSEcCtD
Oxybutynin—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.13e-05	0.000184	CcSEcCtD
Oxybutynin—Vomiting—Felbamate—epilepsy syndrome	3.12e-05	0.000183	CcSEcCtD
Oxybutynin—Dry mouth—Pregabalin—epilepsy syndrome	3.11e-05	0.000183	CcSEcCtD
Oxybutynin—Pruritus—Carbamazepine—epilepsy syndrome	3.11e-05	0.000182	CcSEcCtD
Oxybutynin—Rash—Felbamate—epilepsy syndrome	3.1e-05	0.000182	CcSEcCtD
Oxybutynin—Eye disorder—Topiramate—epilepsy syndrome	3.1e-05	0.000182	CcSEcCtD
Oxybutynin—Dermatitis—Felbamate—epilepsy syndrome	3.09e-05	0.000182	CcSEcCtD
Oxybutynin—Malaise—Gabapentin—epilepsy syndrome	3.09e-05	0.000181	CcSEcCtD
Oxybutynin—Tinnitus—Topiramate—epilepsy syndrome	3.09e-05	0.000181	CcSEcCtD
Oxybutynin—Headache—Felbamate—epilepsy syndrome	3.08e-05	0.000181	CcSEcCtD
Oxybutynin—Confusional state—Pregabalin—epilepsy syndrome	3.08e-05	0.000181	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Oxybutynin—Cardiac disorder—Topiramate—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Oxybutynin—Flushing—Topiramate—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Oxybutynin—Syncope—Gabapentin—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Oxybutynin—Dizziness—Clonazepam—epilepsy syndrome	3.06e-05	0.00018	CcSEcCtD
Oxybutynin—Nausea—Vigabatrin—epilepsy syndrome	3.06e-05	0.00018	CcSEcCtD
Oxybutynin—CHRM1—brain—epilepsy syndrome	3.06e-05	0.0212	CbGeAlD
Oxybutynin—Vomiting—Zonisamide—epilepsy syndrome	3.06e-05	0.000179	CcSEcCtD
Oxybutynin—Insomnia—Valproic Acid—epilepsy syndrome	3.05e-05	0.000179	CcSEcCtD
Oxybutynin—Oedema—Pregabalin—epilepsy syndrome	3.05e-05	0.000179	CcSEcCtD
Oxybutynin—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.05e-05	0.000179	CcSEcCtD
Oxybutynin—Asthenia—Lamotrigine—epilepsy syndrome	3.05e-05	0.000179	CcSEcCtD
Oxybutynin—Dizziness—Phenytoin—epilepsy syndrome	3.04e-05	0.000179	CcSEcCtD
Oxybutynin—Rash—Zonisamide—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Infection—Pregabalin—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Paraesthesia—Valproic Acid—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Palpitations—Gabapentin—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Dermatitis—Zonisamide—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Dizziness—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Oxybutynin—Nausea—Diazepam—epilepsy syndrome	3.02e-05	0.000177	CcSEcCtD
Oxybutynin—Loss of consciousness—Gabapentin—epilepsy syndrome	3.01e-05	0.000177	CcSEcCtD
Oxybutynin—Headache—Zonisamide—epilepsy syndrome	3.01e-05	0.000177	CcSEcCtD
Oxybutynin—Diarrhoea—Carbamazepine—epilepsy syndrome	3.01e-05	0.000176	CcSEcCtD
Oxybutynin—Angiopathy—Topiramate—epilepsy syndrome	3.01e-05	0.000176	CcSEcCtD
Oxybutynin—Pruritus—Lamotrigine—epilepsy syndrome	3e-05	0.000176	CcSEcCtD
Oxybutynin—Shock—Pregabalin—epilepsy syndrome	3e-05	0.000176	CcSEcCtD
Oxybutynin—Somnolence—Valproic Acid—epilepsy syndrome	3e-05	0.000176	CcSEcCtD
Oxybutynin—Nervous system disorder—Pregabalin—epilepsy syndrome	2.99e-05	0.000176	CcSEcCtD
Oxybutynin—Cough—Gabapentin—epilepsy syndrome	2.99e-05	0.000176	CcSEcCtD
Oxybutynin—Mediastinal disorder—Topiramate—epilepsy syndrome	2.99e-05	0.000175	CcSEcCtD
Oxybutynin—Tachycardia—Pregabalin—epilepsy syndrome	2.98e-05	0.000175	CcSEcCtD
Oxybutynin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Oxybutynin—Convulsion—Gabapentin—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Oxybutynin—Skin disorder—Pregabalin—epilepsy syndrome	2.96e-05	0.000174	CcSEcCtD
Oxybutynin—Hypertension—Gabapentin—epilepsy syndrome	2.96e-05	0.000174	CcSEcCtD
Oxybutynin—Vomiting—Clonazepam—epilepsy syndrome	2.95e-05	0.000173	CcSEcCtD
Oxybutynin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.93e-05	0.000172	CcSEcCtD
Oxybutynin—Vomiting—Phenytoin—epilepsy syndrome	2.93e-05	0.000172	CcSEcCtD
Oxybutynin—Rash—Clonazepam—epilepsy syndrome	2.92e-05	0.000172	CcSEcCtD
Oxybutynin—Dermatitis—Clonazepam—epilepsy syndrome	2.92e-05	0.000171	CcSEcCtD
Oxybutynin—Arthralgia—Gabapentin—epilepsy syndrome	2.92e-05	0.000171	CcSEcCtD
Oxybutynin—Chest pain—Gabapentin—epilepsy syndrome	2.92e-05	0.000171	CcSEcCtD
Oxybutynin—Nausea—Felbamate—epilepsy syndrome	2.92e-05	0.000171	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Fatigue—Valproic Acid—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Anxiety—Gabapentin—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Anorexia—Pregabalin—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Dizziness—Carbamazepine—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Oxybutynin—Headache—Clonazepam—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Oxybutynin—Rash—Phenytoin—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Oxybutynin—Mental disorder—Topiramate—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Oxybutynin—Dermatitis—Phenytoin—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Oxybutynin—Rash—Oxcarbazepine—epilepsy syndrome	2.89e-05	0.000169	CcSEcCtD
Oxybutynin—Pain—Valproic Acid—epilepsy syndrome	2.89e-05	0.000169	CcSEcCtD
Oxybutynin—Constipation—Valproic Acid—epilepsy syndrome	2.89e-05	0.000169	CcSEcCtD
Oxybutynin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Oxybutynin—Headache—Phenytoin—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Oxybutynin—Malnutrition—Topiramate—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Oxybutynin—Erythema—Topiramate—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Oxybutynin—Discomfort—Gabapentin—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Oxybutynin—Headache—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000168	CcSEcCtD
Oxybutynin—Nausea—Zonisamide—epilepsy syndrome	2.86e-05	0.000168	CcSEcCtD
Oxybutynin—Dry mouth—Gabapentin—epilepsy syndrome	2.85e-05	0.000168	CcSEcCtD
Oxybutynin—Hypotension—Pregabalin—epilepsy syndrome	2.85e-05	0.000167	CcSEcCtD
Oxybutynin—Flatulence—Topiramate—epilepsy syndrome	2.84e-05	0.000167	CcSEcCtD
Oxybutynin—Tension—Topiramate—epilepsy syndrome	2.83e-05	0.000166	CcSEcCtD
Oxybutynin—Dysgeusia—Topiramate—epilepsy syndrome	2.82e-05	0.000166	CcSEcCtD
Oxybutynin—Confusional state—Gabapentin—epilepsy syndrome	2.82e-05	0.000166	CcSEcCtD
Oxybutynin—Dizziness—Lamotrigine—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Oxybutynin—Nervousness—Topiramate—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Oxybutynin—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Oxybutynin—Oedema—Gabapentin—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Oxybutynin—Vomiting—Carbamazepine—epilepsy syndrome	2.79e-05	0.000164	CcSEcCtD
Oxybutynin—Back pain—Topiramate—epilepsy syndrome	2.79e-05	0.000164	CcSEcCtD
Oxybutynin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Oxybutynin—Infection—Gabapentin—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Oxybutynin—Rash—Carbamazepine—epilepsy syndrome	2.77e-05	0.000163	CcSEcCtD
Oxybutynin—Dermatitis—Carbamazepine—epilepsy syndrome	2.77e-05	0.000162	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.76e-05	0.000162	CcSEcCtD
Oxybutynin—Insomnia—Pregabalin—epilepsy syndrome	2.76e-05	0.000162	CcSEcCtD
Oxybutynin—Nausea—Clonazepam—epilepsy syndrome	2.75e-05	0.000162	CcSEcCtD
Oxybutynin—Headache—Carbamazepine—epilepsy syndrome	2.75e-05	0.000162	CcSEcCtD
Oxybutynin—Shock—Gabapentin—epilepsy syndrome	2.75e-05	0.000162	CcSEcCtD
Oxybutynin—Nervous system disorder—Gabapentin—epilepsy syndrome	2.74e-05	0.000161	CcSEcCtD
Oxybutynin—Paraesthesia—Pregabalin—epilepsy syndrome	2.74e-05	0.000161	CcSEcCtD
Oxybutynin—CHRM3—brain—epilepsy syndrome	2.74e-05	0.019	CbGeAlD
Oxybutynin—Nausea—Phenytoin—epilepsy syndrome	2.73e-05	0.000161	CcSEcCtD
Oxybutynin—Tachycardia—Gabapentin—epilepsy syndrome	2.73e-05	0.00016	CcSEcCtD
Oxybutynin—Nausea—Oxcarbazepine—epilepsy syndrome	2.72e-05	0.00016	CcSEcCtD
Oxybutynin—Vision blurred—Topiramate—epilepsy syndrome	2.72e-05	0.00016	CcSEcCtD
Oxybutynin—Skin disorder—Gabapentin—epilepsy syndrome	2.72e-05	0.00016	CcSEcCtD
Oxybutynin—Somnolence—Pregabalin—epilepsy syndrome	2.71e-05	0.000159	CcSEcCtD
Oxybutynin—Vomiting—Lamotrigine—epilepsy syndrome	2.7e-05	0.000159	CcSEcCtD
Oxybutynin—Urticaria—Valproic Acid—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Oxybutynin—Rash—Lamotrigine—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Oxybutynin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Oxybutynin—Dermatitis—Lamotrigine—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Oxybutynin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.67e-05	0.000157	CcSEcCtD
Oxybutynin—Anorexia—Gabapentin—epilepsy syndrome	2.67e-05	0.000157	CcSEcCtD
Oxybutynin—Headache—Lamotrigine—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Oxybutynin—Decreased appetite—Pregabalin—epilepsy syndrome	2.65e-05	0.000156	CcSEcCtD
Oxybutynin—Agitation—Topiramate—epilepsy syndrome	2.65e-05	0.000156	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.63e-05	0.000155	CcSEcCtD
Oxybutynin—Fatigue—Pregabalin—epilepsy syndrome	2.63e-05	0.000154	CcSEcCtD
Oxybutynin—Hypotension—Gabapentin—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Oxybutynin—Nausea—Carbamazepine—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Oxybutynin—Constipation—Pregabalin—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Oxybutynin—Pain—Pregabalin—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Oxybutynin—Malaise—Topiramate—epilepsy syndrome	2.6e-05	0.000153	CcSEcCtD
Oxybutynin—Syncope—Topiramate—epilepsy syndrome	2.59e-05	0.000152	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.55e-05	0.00015	CcSEcCtD
Oxybutynin—Palpitations—Topiramate—epilepsy syndrome	2.55e-05	0.00015	CcSEcCtD
Oxybutynin—Loss of consciousness—Topiramate—epilepsy syndrome	2.53e-05	0.000149	CcSEcCtD
Oxybutynin—Insomnia—Gabapentin—epilepsy syndrome	2.53e-05	0.000149	CcSEcCtD
Oxybutynin—Nausea—Lamotrigine—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Oxybutynin—Cough—Topiramate—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Oxybutynin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.51e-05	0.000148	CcSEcCtD
Oxybutynin—Paraesthesia—Gabapentin—epilepsy syndrome	2.51e-05	0.000147	CcSEcCtD
Oxybutynin—Convulsion—Topiramate—epilepsy syndrome	2.5e-05	0.000147	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.49e-05	0.000146	CcSEcCtD
Oxybutynin—Hypertension—Topiramate—epilepsy syndrome	2.49e-05	0.000146	CcSEcCtD
Oxybutynin—Somnolence—Gabapentin—epilepsy syndrome	2.49e-05	0.000146	CcSEcCtD
Oxybutynin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.49e-05	0.000146	CcSEcCtD
Oxybutynin—Dyspepsia—Gabapentin—epilepsy syndrome	2.46e-05	0.000145	CcSEcCtD
Oxybutynin—Arthralgia—Topiramate—epilepsy syndrome	2.46e-05	0.000144	CcSEcCtD
Oxybutynin—Chest pain—Topiramate—epilepsy syndrome	2.46e-05	0.000144	CcSEcCtD
Oxybutynin—Anxiety—Topiramate—epilepsy syndrome	2.45e-05	0.000144	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.44e-05	0.000143	CcSEcCtD
Oxybutynin—Decreased appetite—Gabapentin—epilepsy syndrome	2.43e-05	0.000143	CcSEcCtD
Oxybutynin—Discomfort—Topiramate—epilepsy syndrome	2.43e-05	0.000142	CcSEcCtD
Oxybutynin—Urticaria—Pregabalin—epilepsy syndrome	2.42e-05	0.000142	CcSEcCtD
Oxybutynin—Asthenia—Valproic Acid—epilepsy syndrome	2.42e-05	0.000142	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.42e-05	0.000142	CcSEcCtD
Oxybutynin—Fatigue—Gabapentin—epilepsy syndrome	2.41e-05	0.000142	CcSEcCtD
Oxybutynin—Abdominal pain—Pregabalin—epilepsy syndrome	2.41e-05	0.000142	CcSEcCtD
Oxybutynin—Dry mouth—Topiramate—epilepsy syndrome	2.4e-05	0.000141	CcSEcCtD
Oxybutynin—Pain—Gabapentin—epilepsy syndrome	2.39e-05	0.00014	CcSEcCtD
Oxybutynin—Constipation—Gabapentin—epilepsy syndrome	2.39e-05	0.00014	CcSEcCtD
Oxybutynin—Pruritus—Valproic Acid—epilepsy syndrome	2.39e-05	0.00014	CcSEcCtD
Oxybutynin—Confusional state—Topiramate—epilepsy syndrome	2.37e-05	0.000139	CcSEcCtD
Oxybutynin—Oedema—Topiramate—epilepsy syndrome	2.35e-05	0.000138	CcSEcCtD
Oxybutynin—Infection—Topiramate—epilepsy syndrome	2.34e-05	0.000137	CcSEcCtD
Oxybutynin—Shock—Topiramate—epilepsy syndrome	2.32e-05	0.000136	CcSEcCtD
Oxybutynin—Diarrhoea—Valproic Acid—epilepsy syndrome	2.31e-05	0.000136	CcSEcCtD
Oxybutynin—Nervous system disorder—Topiramate—epilepsy syndrome	2.31e-05	0.000135	CcSEcCtD
Oxybutynin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.31e-05	0.000135	CcSEcCtD
Oxybutynin—Tachycardia—Topiramate—epilepsy syndrome	2.3e-05	0.000135	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.29e-05	0.000134	CcSEcCtD
Oxybutynin—Skin disorder—Topiramate—epilepsy syndrome	2.29e-05	0.000134	CcSEcCtD
Oxybutynin—Hypersensitivity—Pregabalin—epilepsy syndrome	2.25e-05	0.000132	CcSEcCtD
Oxybutynin—Anorexia—Topiramate—epilepsy syndrome	2.24e-05	0.000132	CcSEcCtD
Oxybutynin—Dizziness—Valproic Acid—epilepsy syndrome	2.23e-05	0.000131	CcSEcCtD
Oxybutynin—Urticaria—Gabapentin—epilepsy syndrome	2.22e-05	0.00013	CcSEcCtD
Oxybutynin—CYP2C8—brain—epilepsy syndrome	2.22e-05	0.0154	CbGeAlD
Oxybutynin—Abdominal pain—Gabapentin—epilepsy syndrome	2.21e-05	0.00013	CcSEcCtD
Oxybutynin—Hypotension—Topiramate—epilepsy syndrome	2.2e-05	0.000129	CcSEcCtD
Oxybutynin—Asthenia—Pregabalin—epilepsy syndrome	2.19e-05	0.000128	CcSEcCtD
Oxybutynin—Pruritus—Pregabalin—epilepsy syndrome	2.16e-05	0.000127	CcSEcCtD
Oxybutynin—Vomiting—Valproic Acid—epilepsy syndrome	2.15e-05	0.000126	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.14e-05	0.000126	CcSEcCtD
Oxybutynin—Insomnia—Topiramate—epilepsy syndrome	2.13e-05	0.000125	CcSEcCtD
Oxybutynin—Rash—Valproic Acid—epilepsy syndrome	2.13e-05	0.000125	CcSEcCtD
Oxybutynin—Dermatitis—Valproic Acid—epilepsy syndrome	2.13e-05	0.000125	CcSEcCtD
Oxybutynin—Headache—Valproic Acid—epilepsy syndrome	2.11e-05	0.000124	CcSEcCtD
Oxybutynin—Paraesthesia—Topiramate—epilepsy syndrome	2.11e-05	0.000124	CcSEcCtD
Oxybutynin—Somnolence—Topiramate—epilepsy syndrome	2.09e-05	0.000123	CcSEcCtD
Oxybutynin—Diarrhoea—Pregabalin—epilepsy syndrome	2.09e-05	0.000123	CcSEcCtD
Oxybutynin—Dyspepsia—Topiramate—epilepsy syndrome	2.07e-05	0.000122	CcSEcCtD
Oxybutynin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.06e-05	0.000121	CcSEcCtD
Oxybutynin—Decreased appetite—Topiramate—epilepsy syndrome	2.05e-05	0.00012	CcSEcCtD
Oxybutynin—CYP2D6—head—epilepsy syndrome	2.04e-05	0.0142	CbGeAlD
Oxybutynin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.03e-05	0.000119	CcSEcCtD
Oxybutynin—Fatigue—Topiramate—epilepsy syndrome	2.03e-05	0.000119	CcSEcCtD
Oxybutynin—Dizziness—Pregabalin—epilepsy syndrome	2.02e-05	0.000118	CcSEcCtD
Oxybutynin—Pain—Topiramate—epilepsy syndrome	2.01e-05	0.000118	CcSEcCtD
Oxybutynin—Constipation—Topiramate—epilepsy syndrome	2.01e-05	0.000118	CcSEcCtD
Oxybutynin—Asthenia—Gabapentin—epilepsy syndrome	2.01e-05	0.000118	CcSEcCtD
Oxybutynin—Nausea—Valproic Acid—epilepsy syndrome	2e-05	0.000118	CcSEcCtD
Oxybutynin—Pruritus—Gabapentin—epilepsy syndrome	1.98e-05	0.000116	CcSEcCtD
Oxybutynin—CYP3A4—nervous system—epilepsy syndrome	1.97e-05	0.0137	CbGeAlD
Oxybutynin—Vomiting—Pregabalin—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Oxybutynin—Feeling abnormal—Topiramate—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Oxybutynin—CYP2D6—nervous system—epilepsy syndrome	1.94e-05	0.0134	CbGeAlD
Oxybutynin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.92e-05	0.000113	CcSEcCtD
Oxybutynin—Rash—Pregabalin—epilepsy syndrome	1.92e-05	0.000113	CcSEcCtD
Oxybutynin—Dermatitis—Pregabalin—epilepsy syndrome	1.92e-05	0.000113	CcSEcCtD
Oxybutynin—Diarrhoea—Gabapentin—epilepsy syndrome	1.91e-05	0.000112	CcSEcCtD
Oxybutynin—Headache—Pregabalin—epilepsy syndrome	1.91e-05	0.000112	CcSEcCtD
Oxybutynin—CYP3A4—central nervous system—epilepsy syndrome	1.9e-05	0.0132	CbGeAlD
Oxybutynin—Urticaria—Topiramate—epilepsy syndrome	1.87e-05	0.00011	CcSEcCtD
Oxybutynin—CYP2D6—central nervous system—epilepsy syndrome	1.87e-05	0.0129	CbGeAlD
Oxybutynin—Abdominal pain—Topiramate—epilepsy syndrome	1.86e-05	0.000109	CcSEcCtD
Oxybutynin—Dizziness—Gabapentin—epilepsy syndrome	1.85e-05	0.000109	CcSEcCtD
Oxybutynin—CYP2D6—cerebellum—epilepsy syndrome	1.82e-05	0.0126	CbGeAlD
Oxybutynin—Nausea—Pregabalin—epilepsy syndrome	1.81e-05	0.000106	CcSEcCtD
Oxybutynin—Vomiting—Gabapentin—epilepsy syndrome	1.78e-05	0.000104	CcSEcCtD
Oxybutynin—Rash—Gabapentin—epilepsy syndrome	1.76e-05	0.000104	CcSEcCtD
Oxybutynin—Dermatitis—Gabapentin—epilepsy syndrome	1.76e-05	0.000103	CcSEcCtD
Oxybutynin—Headache—Gabapentin—epilepsy syndrome	1.75e-05	0.000103	CcSEcCtD
Oxybutynin—Hypersensitivity—Topiramate—epilepsy syndrome	1.73e-05	0.000102	CcSEcCtD
Oxybutynin—Asthenia—Topiramate—epilepsy syndrome	1.69e-05	9.91e-05	CcSEcCtD
Oxybutynin—Pruritus—Topiramate—epilepsy syndrome	1.67e-05	9.77e-05	CcSEcCtD
Oxybutynin—Nausea—Gabapentin—epilepsy syndrome	1.66e-05	9.75e-05	CcSEcCtD
Oxybutynin—Diarrhoea—Topiramate—epilepsy syndrome	1.61e-05	9.45e-05	CcSEcCtD
Oxybutynin—Dizziness—Topiramate—epilepsy syndrome	1.56e-05	9.14e-05	CcSEcCtD
Oxybutynin—Vomiting—Topiramate—epilepsy syndrome	1.5e-05	8.78e-05	CcSEcCtD
Oxybutynin—Rash—Topiramate—epilepsy syndrome	1.48e-05	8.71e-05	CcSEcCtD
Oxybutynin—Dermatitis—Topiramate—epilepsy syndrome	1.48e-05	8.7e-05	CcSEcCtD
Oxybutynin—CYP2D6—brain—epilepsy syndrome	1.48e-05	0.0103	CbGeAlD
Oxybutynin—Headache—Topiramate—epilepsy syndrome	1.47e-05	8.66e-05	CcSEcCtD
Oxybutynin—Nausea—Topiramate—epilepsy syndrome	1.4e-05	8.21e-05	CcSEcCtD
Oxybutynin—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.62e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.59e-06	7.32e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	4.57e-06	7.3e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	4.52e-06	7.21e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.52e-06	7.21e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.52e-06	7.21e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.51e-06	7.2e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	4.5e-06	7.19e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	4.5e-06	7.19e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.5e-06	7.18e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.5e-06	7.18e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.48e-06	7.15e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.48e-06	7.15e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.48e-06	7.15e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.47e-06	7.13e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.47e-06	7.13e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	4.46e-06	7.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.46e-06	7.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.46e-06	7.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.45e-06	7.11e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.44e-06	7.08e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.43e-06	7.08e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.43e-06	7.08e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.43e-06	7.07e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.42e-06	7.06e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	4.42e-06	7.05e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	4.42e-06	7.05e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.42e-06	7.05e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—TH—epilepsy syndrome	4.41e-06	7.04e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	4.4e-06	7.03e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	4.4e-06	7.02e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—HMOX1—epilepsy syndrome	4.38e-06	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.38e-06	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.38e-06	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.36e-06	6.96e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.33e-06	6.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CAT—epilepsy syndrome	4.32e-06	6.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.31e-06	6.88e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	4.3e-06	6.87e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.3e-06	6.86e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.29e-06	6.84e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.27e-06	6.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.26e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.26e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.2e-06	6.71e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.2e-06	6.7e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.19e-06	6.68e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.17e-06	6.66e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.15e-06	6.62e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.12e-06	6.58e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.11e-06	6.56e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.1e-06	6.54e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	4.09e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.09e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.08e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	4.08e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.08e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.07e-06	6.49e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.07e-06	6.49e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.04e-06	6.45e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.03e-06	6.43e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.03e-06	6.43e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.01e-06	6.41e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.01e-06	6.4e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.01e-06	6.4e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	4e-06	6.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4e-06	6.38e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.97e-06	6.34e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.96e-06	6.31e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.93e-06	6.28e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.93e-06	6.26e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	3.92e-06	6.25e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GPX1—epilepsy syndrome	3.91e-06	6.24e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.9e-06	6.23e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.88e-06	6.19e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.84e-06	6.12e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TH—epilepsy syndrome	3.82e-06	6.1e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	3.81e-06	6.08e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	3.8e-06	6.06e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	3.77e-06	6.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.77e-06	6.02e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.76e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.76e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.76e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	3.76e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	3.76e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	3.75e-06	5.98e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.72e-06	5.94e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.71e-06	5.93e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	3.68e-06	5.88e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.68e-06	5.87e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.64e-06	5.81e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.63e-06	5.8e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.63e-06	5.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.59e-06	5.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.57e-06	5.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.54e-06	5.64e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.44e-06	5.5e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	3.44e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.43e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AGT—epilepsy syndrome	3.43e-06	5.47e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.4e-06	5.42e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.36e-06	5.37e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—APOE—epilepsy syndrome	3.36e-06	5.36e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.35e-06	5.35e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.35e-06	5.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.34e-06	5.33e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.34e-06	5.33e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.34e-06	5.32e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.33e-06	5.31e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.33e-06	5.31e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.32e-06	5.3e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.31e-06	5.27e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.29e-06	5.26e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.29e-06	5.25e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.29e-06	5.24e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.23e-06	5.16e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.23e-06	5.16e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.22e-06	5.14e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.21e-06	5.12e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.19e-06	5.09e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.18e-06	5.08e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.18e-06	5.08e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.18e-06	5.07e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.17e-06	5.06e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.15e-06	5.03e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.15e-06	5.02e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.14e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TH—epilepsy syndrome	3.14e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.1e-06	4.94e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.09e-06	4.93e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.06e-06	4.89e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.06e-06	4.88e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	3.04e-06	4.85e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.03e-06	4.84e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.02e-06	4.82e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.99e-06	4.77e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—POMC—epilepsy syndrome	2.88e-06	4.6e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.88e-06	4.6e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.88e-06	4.59e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	2.87e-06	4.59e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	2.87e-06	4.58e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	2.87e-06	4.57e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.85e-06	4.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.84e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.84e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.82e-06	4.51e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	2.82e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.82e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.81e-06	4.48e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.78e-06	4.44e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.77e-06	4.41e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.76e-06	4.4e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.75e-06	4.39e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.72e-06	4.35e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.66e-06	4.24e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.65e-06	4.23e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.65e-06	4.22e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.64e-06	4.21e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.63e-06	4.2e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—epilepsy syndrome	2.63e-06	4.2e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.62e-06	4.18e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.62e-06	4.18e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.61e-06	4.17e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.58e-06	4.12e-05	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.57e-06	4.1e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.57e-06	4.1e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.55e-06	4.07e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.54e-06	4.06e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.51e-06	4.01e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.5e-06	3.98e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.47e-06	3.94e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.45e-06	3.9e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.43e-06	3.87e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.42e-06	3.86e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.41e-06	3.85e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.4e-06	3.84e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.39e-06	3.81e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.37e-06	3.78e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.36e-06	3.77e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.34e-06	3.73e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.34e-06	3.73e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.33e-06	3.72e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.3e-06	3.67e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.3e-06	3.67e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.22e-06	3.54e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.21e-06	3.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.19e-06	3.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.18e-06	3.48e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.16e-06	3.45e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.14e-06	3.41e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.13e-06	3.4e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.11e-06	3.37e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.1e-06	3.35e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.08e-06	3.32e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	3.29e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TH—epilepsy syndrome	2.05e-06	3.27e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.05e-06	3.27e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.01e-06	3.2e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.99e-06	3.17e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1.98e-06	3.16e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.96e-06	3.13e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.95e-06	3.11e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	1.94e-06	3.1e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.93e-06	3.09e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.92e-06	3.07e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.92e-06	3.06e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.81e-06	2.89e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.8e-06	2.88e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.79e-06	2.86e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.79e-06	2.85e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.79e-06	2.85e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.77e-06	2.82e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.74e-06	2.78e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.73e-06	2.77e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.72e-06	2.75e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.72e-06	2.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	2.73e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.69e-06	2.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.69e-06	2.7e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.69e-06	2.69e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	2.67e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.67e-06	2.67e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.64e-06	2.62e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.64e-06	2.62e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.64e-06	2.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.62e-06	2.59e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.57e-06	2.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.56e-06	2.49e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.56e-06	2.48e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.54e-06	2.46e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.53e-06	2.44e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.52e-06	2.43e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.52e-06	2.42e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.5e-06	2.4e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.38e-06	2.2e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.38e-06	2.2e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.34e-06	2.14e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.31e-06	2.09e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.16e-06	1.85e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.13e-06	1.8e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.64e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—epilepsy syndrome	9.72e-07	1.55e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	9.7e-07	1.55e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	9.67e-07	1.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	9.58e-07	1.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9e-07	1.44e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—epilepsy syndrome	8.42e-07	1.34e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.91e-07	1.1e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.52e-07	7.21e-06	CbGpPWpGaD
